IDiyas

For the Inventor, By the Inventor

Bad Soden am Taunus, Germany

Klaus-Dieter Kampe

USPTO Granted Patents = 15

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 108(Granted Patents)


Location History:

  • Neuenhain, Taunus, DE (1976)
  • Bad Sodem am Taunus, DE (1986)
  • Soden am Taunus, DE (1991)
  • Bad Soden, DE (1996)
  • Bad Soden am Taunus, DE (1981 - 1998)

Company Filing History:

goldMedal15 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1976-1998

Loading Chart...
15 patents (USPTO):Explore Patents
1. 5795899 - Soluble salts of 4-amino-2-(4,4-dimethylimidazolidin-2-on-1-yl) (1998-08-18),
2. 5587476 - Fullerene derivatives, method of synthesizing them and their use (1996-12-24),
3. 5571816 - Pyrimidines (1996-11-05),
4. 5554751 - Aminoureidofullerene and aminothioureidofullerene derivatives and (1996-09-10),
5. 5100890 - Arylmethylazoles and their salts, agents which contain these compounds, (1992-03-31),
6. 5023357 - Arylmethylazole preparation processes (1991-06-11),
7. 4999352 - 1-(1-aryl-2-hydroxyethyl)-imidazoles and salts thereof, medicaments (1991-03-12),
8. 4877878 - 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof, processes (1989-10-31),
9. 4876354 - Arylmethylazoles and their salts, processes for their preparation, (1989-10-24),
10. 4859670 - 2-Azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof, agents (1989-08-22),
11. 4818758 - 2-azolylmethyl-2-phenyl-4-[benzazol-2-yloxy-or-thio-methyl]-1,3 (1989-04-04),
12. 4705792 - 4-amino-2-(imidazolidin-2-on-1-yl)-5-(3-trifluoromet (1987-11-10),
13. 4628109 - 2-ketosulfonamides and process for their preparation (1986-12-09),
14. 4285946 - 4-Amino-2-ureido (or -thioureido)-pyrimidine-5-carboxylic acid anilides (1981-08-25),
15. 3931214 - 2-Amino-2-oxazolines and process for preparing them (1976-01-06),

Title: **The Innovative Contributions of Klaus-Dieter Kampe**

Introduction

Klaus-Dieter Kampe, a notable inventor based in Bad Soden am Taunus, Germany, has made significant contributions to the field of pharmaceuticals with his inventive prowess. With a remarkable portfolio of 15 patents, Kampe's work focuses on creating compounds that address critical health issues, particularly those related to lipid metabolism disorders.

Latest Patents

Among Klaus-Dieter Kampe's latest patents are the soluble salts of 4-amino-2-(4,4-dimethylimidazolidin-2-on-1-yl) and soluble salts of 4-amino-2-(4,4-dimethylimidazolidin-2-on-1-yl)pyrimidine-5-carboxylic acid N-methyl-N-(3-trifluoromethylphenyl)amide. These patents describe a process for preparing these salts, which are utilized as pharmaceuticals and starting materials. The compounds produced from these patents are particularly suitable for treating lipid metabolism disorders by effectively stimulating the hepatic LDL receptor.

Furthermore, the patents detail the synthesis of fullerene derivatives and their applications, showcasing Kampe's innovative approach to pharmaceutical chemistry.

Career Highlights

Klaus-Dieter Kampe's career has been closely associated with Hoechst Aktiengesellschaft, a prominent pharmaceutical company. His research and development efforts have positioned him as a key figure in the advancement of new therapeutic agents that can play crucial roles in health management and disease treatment.

Collaborations

Throughout his career, Kampe has worked alongside esteemed colleagues such as Wolfgang Raether and Walter Dittmar. These collaborations have fostered a dynamic environment for innovation, allowing for the exchange of ideas and accelerating advancements in their respective fields.

Conclusion

Klaus-Dieter Kampe's contributions to the field of pharmaceuticals through his numerous patents reflect his dedication to innovation and improving health outcomes. His work will undoubtedly continue to impact the industry, paving the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…